News Sentiment

GMED sentiment intelligence

Globus Medical news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 55 Balanced news tone 69 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 78.11 Week of 10 Jul 2026
Weighted tone 55/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

78/100 classification confidence.

Company focus 69

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

-2.5% over one week, -2.8% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Globus Medical to Announce Second Quarter 2026 Financial Results on August 6

Market Reaction

Balanced read

63/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 78/100 classification
One-week reaction -2.5% Price reacting lower
Trend fit Trend inactive -2.8% over four weeks
Fair value 13.4% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 23
Neutral 43
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 69
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 19
TradingView 16
Sahm 6
Stock Titan 4
simplywall.st 3
Quiver Quantitative 2
Stock Traders Daily 2
GlobeNewswire 1

Event Lens

What the news is about

Classified themes
Market update 34
Earnings 27
Analyst action 3
Deals and strategy 3
Balance sheet 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 69
Sahm Direct company coverage

Globus Medical (GMED) Stock Could Be 28% Undervalued Despite Recent Share Price Bounce

Globus Medical (GMED) stock has seen a recent bounce but is still down over the past month and three months. Despite a nearly 37% total shareholder return over the last year, the stock is currently perceived by some analyses as 28% undervalued, with a fair value anchored at $110

Tone
Positive 72/100
Event
Market update
Published
21 Jun 2026 23:09
Source
Sahm
Stock Traders Daily Direct company coverage

(GMED) and the Role of Price-Sensitive Allocations

This article analyzes Globus Medical Inc. Class A (NASDAQ: GMED), noting divergent sentiment and potential for lower levels. It details AI-generated trading strategies including position, momentum, and risk hedging, along with multi-timeframe signal analysis for support and resis

Tone
Negative 36/100
Event
Market update
Published
15 Jun 2026 16:00
Source
Stock Traders Daily
Sahm Direct company coverage

Globus Medical (GMED) Stock After 36% One-Year Gain Is There Still Upside?

Globus Medical (GMED) has seen a 36% gain over the past year, prompting an analysis of its current valuation. According to Simply Wall St's discounted cash flow (DCF) model and P/E ratio analysis, the stock appears to be significantly undervalued by approximately 49.6%. The artic

Tone
Positive 75/100
Event
Balance sheet
Published
13 Jun 2026 18:40
Source
Sahm
Market source Direct company coverage

Madison Small Cap Fund Sold Globus Medical (GMED) as Valuation Exceeded

Madison Small Cap Fund liquidated its position in Globus Medical (GMED) after the company successfully integrated its Nuvasive acquisition and saw its market capitalization reach $12 billion, which exceeded the fund's intrinsic value estimate of $85 per share against a market pri

Tone
Negative 39/100
Event
Deals and strategy
Published
12 Jun 2026 10:41
Source
Market source
TradingView Direct company coverage

Total assets of Globus Medical Inc Class A – XETR:GM0N

The article displays the "Total assets" section for Globus Medical Inc Class A (XETR:GM0N) on TradingView. It provides a table structure with columns for "Period," "Value," "Change," and "Change %" but no specific data is populated. This page is part of the financial overview for

Tone
Neutral 50/100
Event
Market update
Published
10 Jun 2026 21:11
Source
TradingView
TradingView Direct company coverage

Preferred dividends of Globus Medical Inc Class A – XETR:GM0N

This page provides information on the preferred dividends of Globus Medical Inc Class A, traded on the XETR exchange under the symbol GM0N. It is part of TradingView's financial data section, offering an overview of market data, financials, news, community insights, and forecasts

Tone
Neutral 50/100
Event
Market update
Published
10 Jun 2026 06:10
Source
TradingView
Stock Titan Direct company coverage

Globus Medical (NYSE: GMED) director exercises options, sells 25,000 shares

Globus Medical director David D. Davidar engaged in an exercise-and-sell transaction, exercising stock options for 25,000 shares at $26.27 each and simultaneously selling those 25,000 shares in the open market for a weighted average price of $80.7629. Following these transactions

Tone
Neutral 50/100
Event
Market update
Published
09 Jun 2026 21:10
Source
Stock Titan
Stock Titan Direct company coverage

Globus Medical (GMED) director exercises options for 25,000 new shares

Globus Medical director Ann D. Rhoads exercised stock options to acquire 25,000 shares of Class A Common Stock at $26.27 per share. These options, granted on January 30, 2017, were fully vested. Following this transaction, Ms. Rhoads now directly owns 40,384 shares of GMED, with

Tone
Neutral 50/100
Event
Market update
Published
08 Jun 2026 21:08
Source
Stock Titan
TradingView Direct company coverage

Tangible book value per share of Globus Medical Inc Class A – XETR:GM0N

This article provides financial information for Globus Medical Inc Class A (XETR:GM0N), specifically focusing on its tangible book value per share. The content is presented within the TradingView platform, which offers various market data and analysis tools for investors.

Tone
Neutral 50/100
Event
Market update
Published
07 Jun 2026 14:40
Source
TradingView